Thiazolidinedione use and the risk of fractures

CMAJ. 2009 Apr 14;180(8):841-2; author reply 842-3. doi: 10.1503/cmaj.1090003.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bone Density / drug effects
  • Case-Control Studies
  • Confidence Intervals
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy
  • Female
  • Follow-Up Studies
  • Fractures, Bone / chemically induced*
  • Fractures, Bone / epidemiology*
  • Greece
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Incidence
  • Male
  • Odds Ratio
  • Pioglitazone
  • Reference Values
  • Risk Assessment
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • 2,4-thiazolidinedione
  • Pioglitazone